Von Willebrand Factor and Platelet Aggregation: from Bench to Clinical Practice
Katrina Ashworth(Center for Cancer and Blood Disorders), Susan M. Shea(University of Iowa), Kimberly A. Thomas(Washington University in St. Louis)
Cited by 4
Related Papers
TNF-α–driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging
|Blood|2019|313
The use of low‐titer group O whole blood is independently associated with improved survival compared to component therapy in adults with severe traumatic hemorrhage
|Transfusion|2020|124
Effect of leukoreduction and pathogen reduction on the hemostatic function of whole blood
|Transfusion|2019|43
The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial
|Frontiers in Immunology|2020|42
Doing more with less: low-titer group O whole blood resulted in less total transfusions and an independent association with survival in adults with severe traumatic hemorrhage
|Journal of Thrombosis and Haemostasis|2023|42